<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5670">
  <stage>Registered</stage>
  <submitdate>17/01/2014</submitdate>
  <approvaldate>17/01/2014</approvaldate>
  <nctid>NCT02042898</nctid>
  <trial_identification>
    <studytitle>Transfusion Requirements in Cardiac Surgery III</studytitle>
    <scientifictitle>An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery</scientifictitle>
    <utrn />
    <trialacronym>TRICS-III</trialacronym>
    <secondaryid>301852</secondaryid>
    <secondaryid>TRICSIII</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Disorder; Heart, Functional, Postoperative, Cardiac Surgery</healthcondition>
  </conditions>
  <interventions>
    <interventions>Other interventions - Restrictive Transfusion Strategy
Other interventions - Liberal transfusion strategy

Active Comparator: Restrictive transfusion strategy - Restrictive transfusion strategy: patients will receive a red cell transfusion if their hemoglobin is &lt;75 g/L (&lt;7.5 g/dL;&lt;4.7mmol/L) intraoperatively and/or postoperatively

Active Comparator: Liberal transfusion strategy - Liberal transfusion strategy: patients will receive a red cell transfusion if their hemoglobin concentration is &lt;95 g/L (&lt;9.5 g/dL&lt;5.9mmol/L) intraoperatively, or postoperatively in the intensive care unit; and/or &lt;85 g/L (&lt; 8.5 g/dL;&lt;5.3mmol/L) on the ward.


Other interventions: Restrictive Transfusion Strategy


Other interventions: Liberal transfusion strategy


</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Composite score of any one of the following: (1) all-cause mortality; (2) myocardial infarction; (3) new renal failure requiring dialysis; or (4) new focal neurological deficit - Composite score of any one of the following events occurring during the index hospitalization (from the start of surgery until hospital discharge or postoperative day 28, whichever comes first): (1) all-cause mortality; (2) myocardial infarction; (3) new renal failure requiring dialysis; or (4) new focal neurological deficit</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of in-hospital all-cause mortality</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of in-hospital myocardial infarction</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of in-hospital new renal failure requiring dialysis</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of in-hospital new focal neurological deficit</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of stay in the ICU and hospital</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Prolonged low output state defined as the need for two or more inotropes for 24 hours or more, intra-aortic balloon pump postoperatively or ventricular assist device</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of mechanical ventilation</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of infection</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Acute kidney injury (defined by Kidney Disease Improving Global Outcomes criteria)</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of gut infarction</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The proportion of patients transfused and the number of blood products and hemostatic products utilized (e.g. red cells, plasma, platelets, cryoprecipitate, factor VII) (index hospitalization)</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Death</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>New onset dialysis (since incident surgery) status</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Stroke</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Coronary revascularization</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Myocardial infarction</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health Care Utilization</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Renal function, based on changes in postoperative serum creatinine</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of Seizures</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of Encephalopathy</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of Delirium</outcome>
      <timepoint>Up to hospital discharge or postoperative day 28 (whichever occurs first)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Age 18 or older

          -  Planned cardiac surgery using cardiopulmonary bypass

          -  Informed consent obtained

          -  Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6
             or more</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients who are unable to receive or who refuse blood products

          -  Patients who are involved in a preoperative autologous pre-donation program

          -  Patients who are having a heart transplant or having surgery solely for an insertion
             of a ventricular assist device

          -  Pregnancy or lactation (a negative pregnancy test must be obtained prior to
             randomization for women of childbearing potential.)

          -  Patients who are unable to receive or who refuse blood products</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Other</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>20/01/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>5028</actualsamplesize>
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/10/2017</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,SA,VIC</recruitmentstate>
    <hospital>Royal Prince Alfred Hospital - Camperdown</hospital>
    <hospital>Royal North Shore Hospital - Sydney</hospital>
    <hospital>Westmead Hospital - Westmead</hospital>
    <hospital>Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>Flinders Medical Centre - Bedford Park</hospital>
    <hospital>Monash Medical Centre - Clayton</hospital>
    <hospital>St Vincent's Hospital, Melbourne - Fitzroy</hospital>
    <hospital>Austin Hospital - Heidelberg</hospital>
    <hospital>Cabrini Health - Malvern</hospital>
    <hospital>Alfred Hospital - Melbourne</hospital>
    <hospital>Barwon Health (University Hospital Geelong) - Melbourne</hospital>
    <hospital>Royal Melbourne Hospital - Parkville</hospital>
    <postcode>2050 - Camperdown</postcode>
    <postcode>2065 - Sydney</postcode>
    <postcode>2145 - Westmead</postcode>
    <postcode>5000 - Adelaide</postcode>
    <postcode>5042 - Bedford Park</postcode>
    <postcode>3168 - Clayton</postcode>
    <postcode>3065 - Fitzroy</postcode>
    <postcode>3084 - Heidelberg</postcode>
    <postcode>3144 - Malvern</postcode>
    <postcode>3004 - Melbourne</postcode>
    <postcode>3220 - Melbourne</postcode>
    <postcode>3050 - Parkville</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Connecticut</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maine</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>Rio de Janeiro</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Alberta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>British Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Manitoba</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>New Brunswick</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Newfoundland and Labrador</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Nova Scotia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Quebec</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state>Shanghai</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Santander</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Bogota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state>Copenhagen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>Tanta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Berlin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Giessen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Greece</country>
      <state>Volos</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Karnataka</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>India</country>
      <state>Gujarat</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Ramat Gan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Tel Aviv</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Kuala Lampur</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Dunedin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hamilton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Wellington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Romania</country>
      <state>TÃ¢rgu-Mure?</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state>Singapore</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>South Africa</country>
      <state>KwaZulu-Natal</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Barcelona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Madrid</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Valencia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Basel</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Bern</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>St. Michael's Hospital, Toronto</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>TRICS-III is an international, multi-centre, open-label randomized controlled trial of two
      commonly used transfusion strategies in high risk patients having cardiac surgery using a
      non-inferiority trial design.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02042898</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>David Mazer, MD</name>
      <address>St. Michael's Hospital, Toronto</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>